Generalized myasthenia gravis is Uplizna’s second new indication this year, after the FDA cleared the anti-CD19 antibody for IgG4-related disease in April.
Prescription opioids may provide short-term anxiety relief for patients with chronic pain, especially among patients with cancer.
FDA Approves Amgen's Uplizna for Generalized Myasthenia Gravis With Positive AChR or MuSK Antibodies
The FDA’s approval of Uplizna for antibody-positive generalized myasthenia gravis introduces a twice-yearly CD19-targeted therapy option for the rare autoimmune condition. The FDA has approved Amgen’s ...
Persons with generalized anxiety disorder (GAD) often feel worried and anxious. These feelings are not confined to a specific time or situation but occur throughout the day. Generalized anxiety ...
Epilepsy isn't one disease or condition. There are many kinds of epilepsy with different symptoms and patterns. It's important to know what kind you have. It can help you and your doctor understand ...
Feeling anxious, worried, or concerned is a normal part of life. However, people with generalized anxiety disorder (GAD) worry so intensely that it interferes with their daily life. GAD is associated ...
Occasionally worrying about an upcoming work presentation, a stressful family situation, or a complicated relationship is a natural part of life. But when that worry becomes excessive, frequent, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results